Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Merus B.V.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Stanford University
Medical College of Wisconsin
National Cancer Institute (NCI)
Ensem Therapeutics
Washington University School of Medicine
AstraZeneca
Sun Yat-sen University
M.D. Anderson Cancer Center
Centre Oscar Lambret
Centre Oscar Lambret
Seagen Inc.
University of Colorado, Denver
Genmab
Seagen Inc.
Seagen Inc.
Fulgent Pharma LLC.
First Affiliated Hospital of Guangxi Medical University
University Hospital, Clermont-Ferrand
Centre Oscar Lambret
National Cancer Institute (NCI)
Centre Oscar Lambret
University of Chicago
Dana-Farber Cancer Institute
Johnson & Johnson Enterprise Innovation Inc.
National Institutes of Health Clinical Center (CC)